Organizer- The GC/CT Self-testing and Self-sampling Working Group Session Description -Roundtable
Discussion: What is Needed to Support At-Home Specimen Collection Devices for GC/CT NAAT Laboratory Testing? Audience -Open to all
Invited opening remarks -The current barriers to remote testing Speaker: Barbara Van Der Pol In brief: Describe a roadmap of where we are and where we want to be (this may entail multiple “destinations” such as health department options, DTC options, etc).
Invited presentation: Potential regulatory pathways and considerations Speaker: Kristian Roth, FDA In brief: Focus on GC/CT collection devices, as opposed to all STIs or self-tests. Assume specimen submission to moderate or high complexity lab with existing capability for result reporting and with link to patient support services.
